PEGylation for enhancing nanoparticle diffusion in mucus☆

Abstract The viscoelastic mucus secretions coating exposed organs such as the lung airways and the female reproductive tract can trap and quickly eliminate not only foreign pathogens and ultrafine particles but also particle‐based drug delivery systems, thus limiting sustained and targeted drug delivery at mucosal surfaces. To improve particle distribution across the mucosa and enhance delivery to the underlying epithelium, many investigators have sought to develop nanoparticles capable of readily traversing mucus. The first synthetic nanoparticles shown capable of rapidly penetrating physiological mucus secretions utilized a dense coating of polyethylene glycol (PEG) covalently grafted onto the surface of preformed polymeric nanoparticles. In the decade since, PEG has become the gold standard in engineering mucus‐penetrating drug carriers for sustained and targeted drug delivery to the lungs, gastrointestinal tract, eyes, and female reproductive tract. This review summarizes the history of the development of various PEG‐based mucus‐penetrating particles, and highlights the key physicochemical properties of PEG coatings and PEGylation strategies to achieve muco‐inert PEG coatings on nanoparticle drug carriers for improved drug and gene delivery at mucosal surfaces. Graphical abstract Figure. No Caption available.

[1]  F. Campbell,et al.  Study of human precorneal tear film thickness and structure using laser interferometry. , 1992, Investigative ophthalmology & visual science.

[2]  Claus-Michael Lehr,et al.  Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus , 2012, Proceedings of the National Academy of Sciences.

[3]  Clive J Roberts,et al.  Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. , 2002, Bioconjugate chemistry.

[4]  P. G. de Gennes,et al.  Conformations of Polymers Attached to an Interface , 1980 .

[5]  Ali Akbar Pourfatollah,et al.  Various methods of gold nanoparticles (GNPs) conjugation to antibodies , 2016 .

[6]  R Weltzin,et al.  Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting , 1996, The Journal of experimental medicine.

[7]  Andrew Emili,et al.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.

[8]  G. P. Martin,et al.  Anti-mucus polyclonal antibody production, purification and linkage to the surface of albumin microspheres. , 2000, International journal of pharmaceutics.

[9]  O. Danos,et al.  Intranasal gene delivery with a polyethylenimine-PEG conjugate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[10]  V. Korolik,et al.  MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. , 2007, The Journal of clinical investigation.

[11]  M. Wirth,et al.  Lectin-mediated bioadhesion: Proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes , 1997 .

[12]  Y. Kawashima,et al.  Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.

[13]  Samuel K. Lai,et al.  Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid) , 2011, Drug Delivery and Translational Research.

[14]  Yen Cu,et al.  Mathematical modeling of molecular diffusion through mucus. , 2009, Advanced drug delivery reviews.

[15]  C. Cai,et al.  "Clickable", polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions. , 2010, Chemical communications.

[16]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[17]  N. Peppas,et al.  Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.

[18]  J. Irache,et al.  Bioadhesion of Lectin-Latex Conjugates to Rat Intestinal Mucosa , 1996, Pharmaceutical Research.

[19]  Claus-Michael Lehr,et al.  Bioadhesion by Means of Specific Binding of Tomato Lectin , 1992, Pharmaceutical Research.

[20]  M. Chilvers,et al.  Local mucociliary defence mechanisms. , 2000, Paediatric respiratory reviews.

[21]  J. Suh,et al.  Gene Delivery to the Lung , 2003 .

[22]  D. Fischer,et al.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.

[23]  David J Brayden,et al.  In Vitro and ex Vivo Intestinal Tissue Models to Measure Mucoadhesion of Poly (Methacrylate) and N-Trimethylated Chitosan Polymers , 2004, Pharmaceutical Research.

[24]  X. Banquy,et al.  Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[25]  N A Peppas,et al.  Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Robinson,et al.  Some biological issues in oral, controlled drug delivery , 1987 .

[27]  A. I. Yudin,et al.  Diffusion of macromolecules and virus-like particles in human cervical mucus. , 2001, Biophysical journal.

[28]  Elizabeth Nance,et al.  A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.

[29]  Anthony P Corfield,et al.  Mucins: a biologically relevant glycan barrier in mucosal protection. , 2015, Biochimica et biophysica acta.

[30]  Benjamin C. Tang,et al.  Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier , 2009, Proceedings of the National Academy of Sciences.

[31]  N. Peppas,et al.  Poly(ethylene glycol)-containing hydrogels in drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[32]  N. Rigby,et al.  Lamellar structures of MUC2-rich mucin: a potential role in governing the barrier and lubricating functions of intestinal mucus. , 2012, Biomacromolecules.

[33]  Mark E. Davis,et al.  PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. , 2004, European journal of cell biology.

[34]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[35]  Benjamin C. Tang,et al.  Vaginal Delivery of Paclitaxel via Nanoparticles with Non‐Mucoadhesive Surfaces Suppresses Cervical Tumor Growth , 2014, Advanced healthcare materials.

[36]  Denis Wirtz,et al.  Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.

[37]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[38]  S. Muro,et al.  Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice , 2012, International journal of nanomedicine.

[39]  D. Leckband,et al.  Direct Measurement of Interactions between Tethered Poly(ethylene glycol) Chains and Adsorbed Mucin Layers , 2002 .

[40]  Zhirong Zhang,et al.  Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[41]  U. Schubert,et al.  Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. , 2011 .

[42]  J. Irache,et al.  Bioadhesive properties of pegylated nanoparticles , 2005, Expert opinion on drug delivery.

[43]  M. Alonso,et al.  The potential of chitosan for the oral administration of peptides , 2005, Expert opinion on drug delivery.

[44]  Jin Chang,et al.  PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.

[45]  Laura M Ensign,et al.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.

[46]  R. Emanuele FLOCOR: a new anti-adhesive, rheologic agent. , 1998, Expert opinion on investigational drugs.

[47]  Laura M Ensign,et al.  Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. , 2016, Nanomedicine.

[48]  Laura M Ensign,et al.  Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. , 2013, Molecular pharmaceutics.

[49]  Laura M Ensign,et al.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.

[50]  Justin Hanes,et al.  A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[51]  J. S. Suk,et al.  Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[52]  S. Lai,et al.  Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus. , 2016, Acta biomaterialia.

[53]  Scott H Randell,et al.  Effective mucus clearance is essential for respiratory health. , 2006, American journal of respiratory cell and molecular biology.

[54]  C. Lehr,et al.  Lectin-mediated drug targeting: history and applications. , 2004, Advanced drug delivery reviews.

[55]  D. Bush,et al.  Twenty-four hour ambulatory nasal pH monitoring. , 2001, Clinical otolaryngology and allied sciences.

[56]  Sarah L. Kieweg,et al.  Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. , 2006, Journal of biomechanical engineering.

[57]  S. Kerss,et al.  A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. , 1982, Clinical science.

[58]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. , 2007, Biomaterials.

[59]  T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[60]  D. Roopenian,et al.  Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection , 2011, Proceedings of the National Academy of Sciences.

[61]  D. Schaffer,et al.  PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. , 2005, Biotechnology and bioengineering.

[62]  Todd M. Allen,et al.  Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo. , 2016, Journal of Infectious Diseases.

[63]  R. N. Palumbo,et al.  Bacterial invasin: structure, function, and implication for targeted oral gene delivery. , 2006, Current drug delivery.

[64]  A. Bernkop‐Schnürch Mucoadhesive systems in oral drug delivery. , 2005, Drug discovery today. Technologies.

[65]  Nicholas A Peppas,et al.  Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[66]  H. Griesser,et al.  Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[67]  K. Ulbrich,et al.  Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy. , 2009, Nano letters.

[68]  Yen Cu,et al.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. , 2009, Molecular pharmaceutics.

[69]  T. Behnke,et al.  Quantification of PEG-maleimide ligands and coupling efficiencies on nanoparticles with Ellman's reagent. , 2015, Analytical chemistry.

[70]  R. Edlich,et al.  Pluronic F-68: a promising new skin wound cleanser. , 1980, Annals of emergency medicine.

[71]  Tian Xia,et al.  Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. , 2013, Accounts of chemical research.

[72]  E. Åkerblom,et al.  Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. , 1983, International archives of allergy and applied immunology.

[73]  J. Sheehan,et al.  Structure and macromolecular properties of cervical mucus glycoproteins. , 1989, Symposia of the Society for Experimental Biology.

[74]  P. Fong,et al.  PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[75]  Samuel K. Lai,et al.  IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections , 2014, Mucosal Immunology.

[76]  D. Thornton,et al.  From mucins to mucus: toward a more coherent understanding of this essential barrier. , 2004, Proceedings of the American Thoracic Society.

[77]  A. Allen,et al.  Gastroduodenal mucosal protection. , 1993, Physiological reviews.

[78]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. , 2006, Biomaterials.

[79]  T. Bhowmick,et al.  Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[80]  I. Gipson Mucins of the human endocervix. , 2001, Frontiers in bioscience : a journal and virtual library.

[81]  K. Whaley,et al.  Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. , 2001, Human reproduction.

[82]  E. Mathiowitz,et al.  Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems. , 1996, Biotechnology and bioengineering.

[83]  H. Florey The secretion and function of intestinal mucus. , 1962, Gastroenterology.

[84]  V. Khutoryanskiy,et al.  POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers. , 2015, Nanoscale.

[85]  Samuel K. Lai,et al.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.

[86]  Dandan Liu,et al.  Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate. , 2017, International journal of biological macromolecules.

[87]  L. Kaminskas,et al.  Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance. , 2011, Journal of pharmaceutical sciences.

[88]  Hongming Chen,et al.  Mucus-penetrating nanoparticles made with "mucoadhesive" poly(vinyl alcohol). , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[89]  Justin Hanes,et al.  Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. , 2011, Angewandte Chemie.

[90]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[91]  Ewen King-Smith,et al.  The thickness of the tear film , 2004, Current eye research.

[92]  A. Herp,et al.  Studies on the isolation and composition of human ocular mucin. , 1988, Experimental eye research.

[93]  N. Willenbacher,et al.  Size-Limited Penetration of Nanoparticles into Porcine Respiratory Mucus after Aerosol Deposition. , 2016, Biomacromolecules.

[94]  Haruki Nakamura,et al.  Nature of the charge distribution in proteins , 1981, Nature.

[95]  P. Mugwe,et al.  Mucociliary Clearance Time in Patients with and without Rhinitis , 2014 .

[96]  J. Mascola,et al.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.

[97]  J M Samet,et al.  The role of airway mucus in pulmonary toxicology. , 1994, Environmental health perspectives.

[98]  M. Qiao,et al.  Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[99]  J. Sheehan,et al.  Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. , 1986, The Biochemical journal.

[100]  P. Artursson,et al.  Biopharmaceutics of Microparticulate Drug Carriers , 1987, Annals of the New York Academy of Sciences.

[101]  K. Popat,et al.  Conformational studies of covalently grafted poly(ethylene glycol) on modified solid matrices using X-ray photoelectron spectroscopy. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[102]  Jenn‐Shing Chen,et al.  Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. , 2009, Biomaterials.

[103]  R. Jain,et al.  Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins , 2016, Drug Delivery and Translational Research.

[104]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[105]  Harendra Arora,et al.  Influenza-binding antibodies immobilise influenza viruses in fresh human airway mucus , 2017, European Respiratory Journal.

[106]  J. S. Suk,et al.  Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. , 2011, Nanomedicine.

[107]  Samuel K. Lai,et al.  Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale , 2009, PloS one.

[108]  J. Hanes,et al.  Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[109]  Benjamin C. Tang,et al.  N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[110]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[111]  J. Pearson,et al.  Upper Airway Mucin Gene Expression: A Review , 2007, The Laryngoscope.

[112]  J. Sheehan,et al.  Structure and macromolecular properties of mucus glycoproteins. , 1988, Monographs in allergy.

[113]  J Woodley,et al.  Bioadhesion: new possibilities for drug administration? , 2001, Clinical pharmacokinetics.

[114]  M. Breunig,et al.  Influence of PEGylation on nanoparticle mobility in different models of the extracellular matrix. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[115]  Raimo Hartmann,et al.  Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.

[116]  A. Hoffman,et al.  Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[117]  O. Mert,et al.  Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. , 2011, Biomaterials.

[118]  H. Fessi,et al.  Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.

[119]  J. Hanes,et al.  The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH. , 2013, Biomacromolecules.

[120]  Justin Hanes,et al.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.

[121]  Benjamin S Schuster,et al.  Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. , 2015, Advanced drug delivery reviews.

[122]  L. Medina-Kauwe,et al.  Intracellular trafficking of nonviral vectors , 2005, Gene Therapy.

[123]  N. Joo,et al.  Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na+] and pH but elevated viscosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[124]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[125]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[126]  H. Florey Mucin and the protection of the body. , 1955, Proceedings of the Royal Society of London. Series B, Biological sciences.

[127]  N. Škalko-Basnet,et al.  Mucoadhesive liposomal delivery systems: the choice of coating material , 2011, Drug development and industrial pharmacy.

[128]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[129]  Michael P Boyle,et al.  The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. , 2009, Biomaterials.

[130]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[131]  M. N. Jones,et al.  Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. , 2000, Biochimica et biophysica acta.

[132]  J. Kreuter,et al.  Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles , 1989 .

[133]  Benjamin C. Tang,et al.  Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation , 2017, Science Advances.

[134]  R. Carrier,et al.  Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids , 2015, Journal of drug targeting.

[135]  N. Peppas,et al.  Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. , 1997, Journal of biomaterials science. Polymer edition.

[136]  G. Russell-Jones,et al.  Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. , 1999, International journal of pharmaceutics.

[137]  J. Kaunitz,et al.  Barrier function of the gastric mucus gel. , 1995, The American journal of physiology.

[138]  A. Bernkop‐Schnürch Thiomers: a new generation of mucoadhesive polymers. , 2005, Advanced drug delivery reviews.

[139]  Clive G. Wilson,et al.  Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .

[140]  Wei Tao,et al.  Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers. , 2016, ACS applied materials & interfaces.

[141]  T. Gerken,et al.  Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light-scattering studies of ovine submaxillary mucin. , 1989, Biochemistry.

[142]  Hongming Chen,et al.  Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles. , 2016, International journal of pharmaceutics.

[143]  B. Hirst,et al.  Lectin-mediated mucosal delivery of drugs and microparticles. , 2000, Advanced drug delivery reviews.

[144]  S. Souto,et al.  esign of cationic lipid nanoparticles for ocular delivery : evelopment , characterization and cytotoxicity , 2013 .

[145]  D. Wirtz,et al.  Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport* , 2003, Journal of Biological Chemistry.

[146]  Zhirong Zhang,et al.  Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. , 2015, ACS nano.

[147]  Scott A. McKinley,et al.  Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus. , 2016, ACS infectious diseases.

[148]  B. Tirosh,et al.  Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions. , 1998, Journal of pharmaceutical sciences.

[149]  J. Hanes,et al.  Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[150]  Gert Storm,et al.  Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.

[151]  J. Chern,et al.  Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. , 1999, Bioconjugate chemistry.

[152]  Elizabeth Nance,et al.  Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[153]  Xue Li,et al.  Micro- and nano-carrier systems: The non-invasive and painless local administration strategies for disease therapy in mucosal tissues. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[154]  B. Hirst,et al.  M-Cell Surface β1 Integrin Expression and Invasin-Mediated Targeting of Yersinia pseudotuberculosis to Mouse Peyer’s Patch M Cells , 1998, Infection and Immunity.

[155]  Jin-Zhi Du,et al.  Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. , 2012, ACS nano.

[156]  J. Cryan,et al.  A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery. , 2012, Organic & biomolecular chemistry.

[157]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[158]  Yoon Yeo,et al.  Recent advances in stealth coating of nanoparticle drug delivery systems. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[159]  Alexander T. Florence,et al.  Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.

[160]  L. Holm,et al.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[161]  J. Rossen,et al.  The MUC family: an obituary. , 2002, Trends in biochemical sciences.

[162]  J. Vergnes,et al.  Fractionation and partial characterization of macromolecular components from human ocular mucus. , 1983, Experimental eye research.

[163]  A. Kros,et al.  The chemical modification of liposome surfaces via a copper-mediated [3 + 2] azide-alkyne cycloaddition monitored by a colorimetric assay. , 2006, Chemical communications.

[164]  H. Takeuchi,et al.  In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[165]  I. Pali-Schöll,et al.  Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[166]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[167]  S. Davis,et al.  In vitro evaluation of the mucoadhesive properties of chitosan microspheres , 1998 .

[168]  Jung Soo Suk,et al.  Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. , 2008, Angewandte Chemie.

[169]  S. Lai,et al.  Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. , 2014, Molecular pharmaceutics.

[170]  Robert Langer,et al.  Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers , 1996, Pharmaceutical Research.

[171]  Claus-Michael Lehr,et al.  An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop , 1991 .

[172]  K. Whaley,et al.  Antibody diffusion in human cervical mucus. , 1994, Biophysical journal.

[173]  G. Giammona,et al.  Pegylated Polyaspartamide-Polylactide-Based Nanoparticles Penetrating Cystic Fibrosis Artificial Mucus. , 2016, Biomacromolecules.

[174]  Kyung‐Yeol Lee,et al.  Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination , 2012, Immune network.

[175]  Gunnar C. Hansson,et al.  The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions , 2010, Proceedings of the National Academy of Sciences.

[176]  Benjamin C. Tang,et al.  Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus , 2012, Science Translational Medicine.

[177]  D. Burton,et al.  Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers , 2009, PLoS pathogens.

[178]  M. A. Arangoa,et al.  Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[179]  G. Woodworth,et al.  Nanoparticle diffusion in respiratory mucus from humans without lung disease. , 2013, Biomaterials.

[180]  James E Bear,et al.  PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. , 2012, Nano letters.

[181]  M D Donovan,et al.  Drug transfer through mucus. , 2001, Advanced drug delivery reviews.

[182]  Samuel K Lai,et al.  Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. , 2016, Analytical chemistry.

[183]  Y. Barenholz,et al.  Differential Adhesion of Normal and Inflamed Rat Colonic Mucosa by Charged Liposomes , 2004, Pharmaceutical Research.

[184]  H. Florey The Croonian Lecture: Mucin and the protection of the body , 1955, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[185]  G. Ponchel,et al.  Gastrointestinal Transit and Mucoadhesion of Colloidal Suspensions of Lycopersicon Esculentum L. and Lotus Tetragonolobus Lectin-PLA Microsphere Conjugates in Rats , 2001, Pharmaceutical Research.

[186]  D. Quintanar-Guerrero,et al.  In vitro evaluation of the bioadhesive properties of hydrophobic polybasic gels containing N,N-dimethylaminoethyl methacrylate-co-methyl methacrylate. , 2001, Biomaterials.

[187]  O. Farokhzad,et al.  Polymeric nanoparticle drug delivery technologies for oral delivery applications , 2015, Expert opinion on drug delivery.

[188]  U. Ulmsten,et al.  Isolation and characterization of human cervical-mucus glycoproteins. , 1983, The Biochemical journal.

[189]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[190]  A. Kim,et al.  Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[191]  C. Valenta The use of mucoadhesive polymers in vaginal delivery. , 2005, Advanced drug delivery reviews.

[192]  Rihe Liu,et al.  The smart targeting of nanoparticles. , 2013, Current pharmaceutical design.

[193]  R. Gurny,et al.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. , 1998, Advanced drug delivery reviews.

[194]  D. Wei,et al.  Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase , 2012, PloS one.

[195]  Xiaoqun Gong,et al.  Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. , 2015, ACS nano.

[196]  A. Verkman,et al.  Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. , 2003, American journal of physiology. Cell physiology.

[197]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[198]  Juan B. Blanco-Canosa,et al.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.

[199]  J. Irache,et al.  In vitro study of lectin-latex conjugates for specific bioadhesion , 1994 .

[200]  R. Cone,et al.  Barrier properties of mucus. , 2009, Advanced drug delivery reviews.

[201]  R. Langer,et al.  Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.

[202]  Y. Huang,et al.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[203]  Feng Zan,et al.  Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[204]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[205]  Y. Yoshioka,et al.  Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response. , 2012, Biological & pharmaceutical bulletin.

[206]  Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. , 2013, Angewandte Chemie.

[207]  Claus-Michael Lehr,et al.  Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa , 2001, Pharmaceutical Research.

[208]  Jeffrey A. Hubbell,et al.  Materials engineering for immunomodulation , 2009, Nature.

[209]  Patrick J. Sinko,et al.  Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin , 1997 .

[210]  S. Ostad,et al.  Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation , 2011, International journal of nanomedicine.

[211]  Min Liu,et al.  Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration. , 2017, International journal of pharmaceutics.

[212]  J. S. Suk,et al.  MR image‐guided delivery of cisplatin‐loaded brain‐penetrating nanoparticles to invasive glioma with focused ultrasound , 2017, Journal of controlled release : official journal of the Controlled Release Society.